Literature DB >> 1750432

Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I.

T C Friedman1, P M Thomas, T A Fleisher, P Feuillan, R I Parker, F Cassorla, G P Chrousos.   

Abstract

PURPOSE: This study assesses the occurrence of asplenism and gallstones in patients with autoimmune polyglandular disease type I (APG I). PATIENTS AND METHODS: Nine patients with APG I (ages 14 to 48) were studied at the National Institutes of Health. Each patient received endocrine testing, a careful examination of his or her peripheral blood smear, lymphocyte immunophenotyping, a liver-spleen scan, and either an upper abdominal ultrasound or a computer-assisted tomogram to evaluate the spleen and gallbladder.
RESULTS: We documented asplenism in four patients and cholelithiasis in four patients, with two patients having both conditions. The patients with asplenism had Howell-Jolly bodies on peripheral blood smears, lack of splenic uptake by liver-spleen scan, and absent spleens by abdominal computed tomographic scan or ultrasound evaluation. The clinical presentation of the patients with cholelithiasis ranged from acute symptoms requiring surgery to asymptomatic gallstones. Lymphocyte immunophenotyping did not reveal consistent changes in either B- or T-cell subpopulations in the patients studied.
CONCLUSION: Asplenism and gallstones occur frequently in patients with APG I. In addition to careful examination of the peripheral blood smear for Howell-Jolly bodies to screen for asplenism, we recommend an abdominal ultrasound to detect asplenism and/or gallstones in all patients with APG I. Appropriate immunizations and antibiotic coverage may be helpful in those patients with absent spleens.

Entities:  

Mesh:

Year:  1991        PMID: 1750432     DOI: 10.1016/0002-9343(91)90215-j

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

Review 1.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

Authors:  Elise M N Ferré; Timothy J Break; Peter D Burbelo; Michael Allgäuer; David E Kleiner; Dakai Jin; Ziyue Xu; Les R Folio; Daniel J Mollura; Muthulekha Swamydas; Wenjuan Gu; Sally Hunsberger; Chyi-Chia R Lee; Anamaria Bondici; Kevin W Hoffman; Jean K Lim; Kerry Dobbs; Julie E Niemela; Thomas A Fleisher; Amy P Hsu; Laquita N Snow; Dirk N Darnell; Samar Ojaimi; Megan A Cooper; Martin Bozzola; Gary I Kleiner; Juan C Martinez; Robin R Deterding; Douglas B Kuhns; Theo Heller; Karen K Winer; Arun Rajan; Steven M Holland; Luigi D Notarangelo; Kevin P Fennelly; Kenneth N Olivier; Michail S Lionakis
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

3.  Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Elise M N Ferre; Stacey R Rose; Sergio D Rosenzweig; Peter D Burbelo; Kimberly R Romito; Julie E Niemela; Lindsey B Rosen; Timothy J Break; Wenjuan Gu; Sally Hunsberger; Sarah K Browne; Amy P Hsu; Shakuntala Rampertaap; Muthulekha Swamydas; Amanda L Collar; Heidi H Kong; Chyi-Chia Richard Lee; David Chascsa; Thomas Simcox; Angela Pham; Anamaria Bondici; Mukil Natarajan; Joseph Monsale; David E Kleiner; Martha Quezado; Ilias Alevizos; Niki M Moutsopoulos; Lynne Yockey; Cathleen Frein; Ariane Soldatos; Katherine R Calvo; Jennifer Adjemian; Morgan N Similuk; David M Lang; Kelly D Stone; Gulbu Uzel; Jeffrey B Kopp; Rachel J Bishop; Steven M Holland; Kenneth N Olivier; Thomas A Fleisher; Theo Heller; Karen K Winer; Michail S Lionakis
Journal:  JCI Insight       Date:  2016-08-18

4.  [Polyglandular autoimmune syndromes].

Authors:  A Maurer; A Schwarting; G J Kahaly
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

Review 5.  Autoimmune polyglandular syndromes.

Authors:  Aaron W Michels; Peter A Gottlieb
Journal:  Nat Rev Endocrinol       Date:  2010-03-23       Impact factor: 43.330

6.  Chronic active hepatitis in the type I polyglandular autoimmune syndrome.

Authors:  T M Michele; J Fleckenstein; A R Sgrignoli; P J Thuluvath
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

7.  A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1.

Authors:  S H Pearce; T Cheetham; H Imrie; B Vaidya; N D Barnes; R W Bilous; D Carr; K Meeran; N J Shaw; C S Smith; A D Toft; G Williams; P Kendall-Taylor
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1.

Authors:  Uri Pollak; Zvi Bar-Sever; Vered Hoffer; Nufar Marcus; Oded Scheuerman; Ben Zion Garty
Journal:  Eur J Pediatr       Date:  2008-05-22       Impact factor: 3.183

Review 9.  Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED.

Authors:  D Moraes-Vasconcelos; B T Costa-Carvalho; T R Torgerson; H D Ochs
Journal:  J Clin Immunol       Date:  2008-02-09       Impact factor: 8.317

10.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation.

Authors:  Donatella Capalbo; Lucia De Martino; Giuliana Giardino; Raffaella Di Mase; Iolanda Di Donato; Giancarlo Parenti; Pietro Vajro; Claudio Pignata; Mariacarolina Salerno
Journal:  Int J Endocrinol       Date:  2012-10-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.